<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="5545" whole_study_id="5545" phs="000181" v="1" p="1" createDate="2009-04-15T14:47:24-05:00" modDate="2018-06-25T14:12:39-05:00" maxParentChildStudyModDate="2018-06-25T14:12:39-05:00" handle="CIDR_Alcohol"><StudyInfo accession="phs000181.v1.p1" parentAccession="phs000181.v1.p1"><BioProject id="PRJNA75489" entrez_id="75489" type="bp_admin_access"/><BioProject id="PRJNA75491" entrez_id="75491" type="bp_data_submission"/><StudyNameEntrez>CIDR_Alcoholism</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="No"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><Description>
&lt;p&gt;The Australian twin-family study of alcohol use disorder (OZALC study) derives from telephone diagnostic interview

 studies of two general population volunteer cohorts of Australian twins (cohort 1, mostly born 1940-1964; cohort 2, born

 1964-71) and the spouses of the former cohort - a total of over 11,000 families.  Three coordinated studies, using a shared

 assessment protocol and with a shared goal of gene-discovery, were conducted - one funded by the National Institute on Drug

 Abuse, the others by the National Institute on Alcoholism and Alcohol Abuse - by investigators associated with the Midwest

 Alcoholism Research Center at Washington University in St. Louis, and investigators at Queensland Institute of Medical

 Research, Brisbane, Australia (led by Professor Nicholas Martin), using informative families identified from these cohorts.

 The first of these (NIDA Nicotine Addiction Genetics [NAG] project, PI Pamela Madden) identified index cases from the 3 cohorts

 with a history of heavy smoking (smoked 20 or more cigarettes daily, or 40 or more cigarettes on 1 or more occasions) and

 with additional available full siblings who were smokers, and interviewed and obtained blood samples from twins, and

 cooperative full siblings and parents, in order to identify families that would be informative for linkage analysis of a

 quantitative heaviness of smoking trait.  The second identified additional families with an index case who either reported a

 history of alcohol dependence (DSM-IV), or scored above the 85th percentile on a quantitative measure of heaviness of alcohol

 use (alcohol factor score), derived from measures of frequency of heavy drinking, frequency of drinking to intoxication,

 and typical weekly consumption in standard drinks (all referenced to the respondent&amp;#39;s heaviest drinking period) and of

 lifetime maximum 1-day alcohol consumption and maximum tolerance to alcohol (drinks before getting drunk or before feeling

 effects of alcohol).  Interview and DNA were obtained from index cases and siblings, and DNA only from available parents.

 The goal of this second study (NIAAA OZ-ALCOHOL EDAC study, PI Andrew Heath) was to identify sibships including pairs who

 were either extreme concordant for the quantitative consumption measure (both scoring above the 85th percentile) or extreme

 discordant (one scoring above the 85th percentile and one scoring below the 30th percentile) that would be informative for

 linkage analysis.  The third identified additional sibships solely on the basis of large sibship size, regardless of alcohol

 or tobacco use phenotypes (NIAAA OZ-BIGSIB study, PIs the late Richard Todd, Andrew Heath).  From these coordinated studies

 a case-control series of alcohol dependent individuals and unaffected controls were constructed for a family-based Genomewide

 Association Study (OZALC-GWAS) of heaviness of alcohol use and alcohol dependence, funded by the National Institute of

 Alcoholism and Alcohol Abuse.  These data are made available here for all investigators studying outcomes related to alcohol

 or tobacco use (including major depressive disorder).&lt;/p&gt;
 </Description><StudyHistory>
&lt;table&gt;

 &lt;tr&gt;

  &lt;td&gt;1979-1981&lt;/td&gt;

  &lt;td&gt;Australian Alcohol Challenge Twin Study (subsample of cohort 1 twins, N=412)&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1980-1982&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 1 Questionnaire mailing&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1988-1990&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 1 Questionnaire follow-up&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1988-1990&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 2 Questionnaire mailing&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1992-1993&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 1 Diagnostic Interview Survey, Phase 1&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1994-1996&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 1 Diagnostic Interview Survey, Phase 2&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1994-1997&lt;/td&gt;

  &lt;td&gt;Diagnostic Interview Survey of Spouses of Cohort 1 Twins&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;1996-2000&lt;/td&gt;

  &lt;td&gt;Australian Twin Cohort 2 Diagnostic Interview Survey&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;2000-2006&lt;/td&gt;

  &lt;td&gt;Nicotine Addiction Genetics study, data-collection and linkage phase&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;2001-2008&lt;/td&gt;

  &lt;td&gt;OZALC-EDAC study, data-collection and genotyping phase&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;2001-2009&lt;/td&gt;

  &lt;td&gt;OZALC-BIGSIB study, data-collection and genotyping phase&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;01/2008&lt;/td&gt;

  &lt;td&gt;Approval for GWAS genotyping by CIDR&lt;/td&gt;

 &lt;/tr&gt;

 &lt;tr&gt;

  &lt;td&gt;2009&lt;/td&gt;

  &lt;td&gt;GWAS data released by CIDR&lt;/td&gt;

 &lt;/tr&gt;

 &lt;/table&gt;
 </StudyHistory><Attributions><Header title="Principal Investigator, OZALC-EDAC Project (2001-2008)"><AttrName>Andrew C. Heath, DPhil</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA  (Lead Institution)</Institution></Header><Header title="Principal Investigator, OZALC-BIGSIB Project (2008-2009)"><AttrName>Andrew C. Heath, DPhil</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA  (Lead Institution)</Institution></Header><Header title="Principal Investigator, OZALC-BIGSIB Project (2002-2008, deceased)"><AttrName>Richard D. Todd, PhD, MD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA  (Lead Institution)</Institution></Header><Header title="Principal Investigator, NAG Project (1999-2009)"><AttrName>Pamela A. Madden, PhD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA  (Lead Institution)</Institution></Header><Header title="Co-Investigator and Project Statistician, OZALC-BIGSIB Project"><AttrName>Alexandre Todorov, PhD</AttrName><Institution>Washington University School of Medicine, St. Louis, MO, USA  (Lead Institution)</Institution></Header><Header title="Site Principal Investigator, NAG, OZALC-EDAC and OZALC-BIGSIB Projects"><AttrName>Nicholas G. Martin, PhD</AttrName><Institution>Queensland Institute of Medical Research, Brisbane, Australia (Data-Collection Site)</Institution></Header><Header title="Co-Principal Investigator and Site Molecular Geneticist, NAG, OZALC-EDAC and OZALC-BIGSIB Projects"><AttrName>Grant Montgomery, PhD</AttrName><Institution>Queensland Institute of Medical Research, Brisbane, Australia (Data-Collection Site)</Institution></Header><Header title="Co-Principal Investigator and Site Clinical Biochemist, NAG, OZALC-EDAC and OZALC-BIGSIB Projects"><AttrName>John Whitfield, PhD</AttrName><Institution>Queensland Institute of Medical Research, Brisbane, Australia (Data-Collection Site)</Institution></Header><Header title="Funding Source for CIDR Genotyping"><AttrName>HHSN268200782096C. NIH contract "High throughput genotyping for studying the genetic contributions to human disease"</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="Midwest Alcoholism Research Center" url="http://www.alcoholdependence.org"/></StudyURLs><Publications><Publication><Pubmed pmid="2927121"/></Publication><Publication><Pubmed pmid="2927121"/></Publication><Publication><Pubmed pmid="7733853"/></Publication><Publication><Pubmed pmid="9403910"/></Publication><Publication><Pubmed pmid="11931689"/></Publication><Publication><Pubmed pmid="14993113"/></Publication><Publication><Pubmed pmid="15318113"/></Publication><Publication><Pubmed pmid="15500307"/></Publication><Publication><Pubmed pmid="15724882"/></Publication><Publication><Pubmed pmid="16354499"/></Publication><Publication><Pubmed pmid="17378921"/></Publication><Publication><Pubmed pmid="17436240"/></Publication><Publication><Pubmed pmid="18996923"/></Publication><Publication><Pubmed pmid="19193628"/></Publication><Publication><Pubmed pmid="19261227"/></Publication><Publication><Pubmed pmid="19576574"/></Publication><Publication><Journal authors="Heath AC, Bucholz KK, Slutske WS, Madden PAF, Dinwiddie SH, Dunne MP, Statham DJ, Whitfield JB, Martin NG, Eaves LJ" title="The assessment of alcoholism in surveys of the general community: what are we measuring?  Some insights from the Australian twin panel survey" journal="International Review of Psychiatry. 1994; 6:295-307"/></Publication></Publications><Funding>R37 AA007728-18</Funding></StudyInfo><Authority><ICs><IC id="15" name="NHGRI" is_funding_ic="false" is_admin_ic="false"/><IC id="14" name="NIAAA" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="ACHIEFMO" aid="2" auth="eRA" login="ACHIEFMO" fname="Andrew" mname="C." lname="Heath" email="aheath@wustl.edu"><Role>PI</Role><Organization>WASHINGTON UNIVERSITY</Organization></Person><Person nedid="0014297184" aid="1" auth="cit" login="parsiana" fname="Abbas" mname="" lname="Parsian" email="parsiana@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0013043239" aid="1" auth="cit" login="pretels" fname="Renate" mname="S" lname="Pretel" email="pretels@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010148423" aid="1" auth="cit" login="anoronha" fname="Antonio" mname="B" lname="Noronha" email="anoronha@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="6 months"><acknowledgement_statement>Funding support for the [CIDR-OZ-ALC GWAS] was provided through the [the Center for Inherited Disease Research (CIDR) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). [CIDR-OZ-ALC GWAS] is a genome-wide association studies funded as part of the NIAAA grant 5 R01 AA013320-04. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by the [CIDR-OZ-ALC GWAS]. Assistance with data cleaning was provided by the National Center for Biotechnology Information. Support for collection of datasets and samples was provided by the MARC: Risk Mechanisms in Alcoholism and Comorbidity (MARC; P60 AA011998-11). Funding support for genotyping, which was performed at the Johns Hopkins University Center for Inherited Disease Research, was provided by the NIH GEI (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). </acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="102" CGType="cg_class_other" title="Research on Alcohol and Tobacco Related Phenotypes" name="RATRP" dac_uid="57" dac_name="JAAMH" irb-approval-required="Yes"><Use-Restriction>Consented to general research use with respect to alcohol and tobacco related phenotypes.</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>